Matthias Kroiss Selected Research

Adrenocortical Adenoma (Disease, Conn's)

4/2021	Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
1/2021	Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations.
1/2021	PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylation.
8/2017	Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Kroiss Research Topics

Disease

50	Neoplasms (Cancer) 04/2024 - 01/2011
45	Adrenocortical Carcinoma 02/2024 - 02/2010
16	Cushing Syndrome 05/2023 - 06/2011
10	Paraganglioma (Paragangliomas) 04/2024 - 01/2019
9	Pheochromocytoma 04/2024 - 01/2019
9	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 01/2018
8	Adenoma (Adenomas) 01/2023 - 08/2015
5	Disease Progression 11/2023 - 06/2012
5	Hypertension (High Blood Pressure) 01/2023 - 04/2014
5	medullary Thyroid cancer 07/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 09/2023 - 08/2017
4	Adrenal incidentaloma 01/2023 - 01/2021
4	Hyperplasia 05/2022 - 01/2017
4	Adrenocortical Adenoma (Disease, Conn's) 04/2021 - 08/2017
3	Obesity 04/2023 - 12/2006
3	Essential Hypertension 10/2022 - 01/2021
2	Infections 03/2024 - 04/2023
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2023 - 08/2021
2	Hyperaldosteronism (Conn Syndrome) 10/2022 - 01/2021
2	Pituitary ACTH Hypersecretion 09/2022 - 01/2022
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 10/2020
2	Lymphatic Metastasis 01/2021 - 02/2019
2	Hyponatremia 01/2020 - 08/2018
2	Carcinoma (Carcinomatosis) 01/2020 - 08/2015
2	Fatigue 10/2019 - 04/2015
2	Rare Diseases (Rare Disease) 12/2018 - 12/2016
1	Hematologic Neoplasms (Hematological Malignancy) 05/2024
1	Pain (Aches) 04/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024
1	COVID-19 03/2024
1	Wounds and Injuries (Trauma) 03/2024
1	Neuroblastoma 01/2024

Drug/Important Bio-Agent (IBA)

23	Mitotane (Lysodren)FDA Link 01/2024 - 02/2010
13	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2023 - 04/2014
11	SteroidsIBA 03/2023 - 06/2011
9	Hormones (Hormone)IBA 01/2023 - 06/2011
7	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2019
5	Etoposide (VP 16)FDA LinkGeneric 09/2023 - 02/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 02/2010
5	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 02/2010
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2017
5	cabozantinibIBA 01/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2008
4	LipidsIBA 01/2024 - 11/2015
4	Sunitinib (Sutent)FDA Link 11/2023 - 01/2011
4	Phosphotransferases (Kinase)IBA 11/2023 - 06/2021
4	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2023 - 01/2021
4	GlucocorticoidsIBA 04/2023 - 11/2011
4	vandetanib (ZD6474)IBA 01/2021 - 01/2018
3	pembrolizumabIBA 09/2023 - 01/2021
3	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2021
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2023 - 01/2019
3	selpercatinibIBA 01/2023 - 01/2020
3	TransferasesIBA 01/2022 - 11/2015
3	CatecholaminesIBA 01/2022 - 12/2019
3	SterolsIBA 01/2022 - 11/2015
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 12/2019
3	lenvatinibIBA 10/2021 - 01/2021
2	cyclopropapyrroloindoleIBA 09/2023 - 11/2021
2	Corticotropin-Releasing HormoneIBA 05/2023 - 01/2022
2	AldosteroneIBA 01/2023 - 01/2021
2	Gemcitabine FDA Link 01/2022 - 11/2017
2	EnzymesIBA 01/2022 - 11/2021
2	Sorafenib (BAY 43-9006)FDA Link 10/2021 - 01/2020
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021 - 01/2021
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021 - 12/2020
2	CateninsIBA 01/2021 - 06/2011
2	prolinedithiocarbamate (PDTC)IBA 01/2021 - 01/2021
2	Chemokine ReceptorsIBA 01/2020 - 01/2017
2	PolyaminesIBA 01/2020 - 08/2017
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 06/2012 - 02/2010
1	Chimeric Antigen ReceptorsIBA 05/2024
1	CannabinoidsIBA 04/2024
1	CannabidiolIBA 04/2024
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2024
1	LigandsIBA 02/2024
1	7-dehydrocholesterolIBA 01/2024
1	Temozolomide (Temodar)FDA LinkGeneric 11/2023
1	Dacarbazine (DIC)FDA LinkGeneric 11/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	Radioisotopes (Radionuclides)IBA 11/2023
1	Vincristine (Oncovin)FDA LinkGeneric 11/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2023
1	larotrectinibIBA 11/2023
1	entrectinibIBA 11/2023
1	TropomyosinIBA 11/2023

Therapy/Procedure

25	Therapeutics 05/2024 - 02/2010
10	Drug Therapy (Chemotherapy) 11/2023 - 04/2015
4	Adrenalectomy 03/2024 - 01/2021
4	Immunotherapy 06/2023 - 01/2020
2	Radiotherapy 01/2023 - 12/2016
2	Renal Dialysis (Hemodialysis) 10/2021 - 06/2014
2	Precision Medicine 12/2018 - 01/2017
2	Salvage Therapy 01/2016 - 02/2010
1	Operative Surgical Procedures 03/2024
1	Length of Stay 03/2024
1	Cryosurgery 02/2024
1	Brachytherapy 09/2023